The Pharmacy Times® Coronavirus Disease Resource Center is a comprehensive resource for clinical news and expert insights on COVID-19, an infectious disease caused by the SARS-CoV-2 virus, including vaccine information and treatments for the disease.
March 4th 2024
Study findings suggest that biomarkers could provide greater insight into different disease mechanisms and how treatments options could be more beneficial for certain patients.
March 1st 2024
Individuals with persistent COVID-19 symptoms had an objectively greater cognitive deficit than individuals had never had COVID-19.
February 26th 2024
“I’m better than I was before I had long COVID, and in so many ways,” said a patient in an interview with Pharmacy Times.
February 14th 2024
Black History Month provides a reminder of the systemic barriers facing many Americans
February 13th 2024
The findings suggest that 6 months after vaccination with ARCT-154, individuals had a longer immune response.
Risks and Liabilities in Pharmacy Practice
1.0 Credit / Law
View More
Opportunities to Reduce Barriers to HPV Vaccination: Key Updates for Pharmacists
1.5 Credits / Immunization
View More
Reducing Barriers Associated With Pneumococcal Vaccine Uptake
1.5 Credits / Immunization, Infectious Diseases
View More
Reducing the Incidence and Severity of RSV in Older Adults: Opportunities for Patient Identification and Vaccination Counseling
1.0 Credit / Infectious Diseases, Pulmonology/Respiratory
View More
Vaccine-Preventable Diseases: Strategies for Addressing Vaccine Hesitancy and Improving Vaccine Confidence
1.0 Credit / Immunization
View More
The Expanding Landscape of Vaccinations for the Prevention of Pneumococcal Disease: The Role of the Pharmacist as Patient Educator and Vaccinator
1.0 Credit / Pneumococcal Disease
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Examining the Evidence for Emerging Vaccines to Prevent RSV-Related Complications in Older Adults
2.0 Credits / Infectious Diseases, Respiratory, Immunization
View More
Influenza Prevention in the At-Risk Adult Population and the Pharmacist's Role in an Evolving Influenza Vaccine Landscape
1.25 Credits / Immunization, Infectious Disease
View More
Identifying Candidates for Meningococcal Vaccines (Pharmacy Technician Credit)
2.0 Credits / Immunization
View More
Identifying Candidates for Meningococcal Vaccines (Pharmacist Credit)
2.0 Credits / Immunization
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Nobel Prize Awarded to Scientists Whose Work Led to Development of mRNA COVID-19 Vaccines
October 2nd 2023Katalin Karikó, PhD, and Drew Weissman, MD, PhD, win Nobel Prize for discoveries in the area of nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Read More
Possible Link Between Depression, Limited Social Interactions During COVID-19 Pandemic
September 28th 2023Study findings showed a 10% increase in the proportion of individuals staying home due to COVID-19 policy restrictions being associated with a 0.27 increase in PHQ-9 scores for depression.
Read More
2 Commerce Drive
Cranbury, NJ 08512